High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/10/1479/647185/mdl044.pdf
Reference96 articles.
1. Dose: a critical factor in cancer chemotherapy;Frei;Am J Med,1980
2. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor;Siena;Blood,1989
3. Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients;Schmitz;Lancet,1996
4. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy;Siena;J Clin Oncol,2000
5. Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial;Nitz;Lancet,2005
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Solid Tumours;The EBMT Handbook;2024
2. Efficacy of Pre-Transplant Chest Physical Therapy on Spiromertic values and Respiratory Muscle Strength in Patients Waiting for Allogeneic Hematopoietic Stem Cell Transplantation”: A randomized Controlled Trial;Archives of Medical Science;2022-07-08
3. Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic;TURKISH JOURNAL OF MEDICAL SCIENCES;2021
4. Graft-versus-cancereffect and innovative approaches in the treatment of refractory solid tumors;TURKISH JOURNAL OF MEDICAL SCIENCES;2020-11-03
5. Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis;Cancers;2020-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3